The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential
- 9 July 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 319 (4), 1327-1333
- https://doi.org/10.1016/j.bbrc.2004.05.105
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 27 references indexed in Scilit:
- ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165Online Journal of Public Health Informatics, 2003
- ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitorsBiochemical and Biophysical Research Communications, 2002
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasisTrends in Cell Biology, 2001
- The Exon/Intron Organization and Chromosomal Mapping of the Mouse ADAMTS-1 Gene Encoding an ADAM Family Protein with TSP MotifsGenomics, 1997
- Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated GenePublished by Elsevier BV ,1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions.The Journal of cell biology, 1995
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994